🇺🇸 FDA
Patent

US 11465972

Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof

granted A61KA61K31/415A61K31/4164

Quick answer

US patent 11465972 (Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/415, A61K31/4164